Ingevity posts Q2 net loss of $146.5M on $183.8M goodwill impairment; adjusted EPS up 38% to $1.39

Ingevity Corp

2025-Q2 EPS reported -$3.46 revenue$649,100,000

Net sales $365.1M, down 7% YoY, led by lower Performance Chemicals volumes.
Net loss $146.5M ($4.02 diluted loss) includes $183.8M non-cash goodwill impairment.
Adjusted earnings $51.1M (+39%); adjusted diluted EPS $1.39 (+38%).
Adjusted EBITDA $110.0M (+9%), margin improved to 30.1% on repositioning actions.
Raises low-end of adjusted EBITDA guidance to $390–$415M; sales guidance reaffirmed at $1.25–$1.40B.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.